PFS Partners’s Zimmer Biomet ZBH Stock Holding History

PFS Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-21	Closed	-$1.79K	–	622
2026 Q2	$1.79K	Hold	21	–	–	﹤0.01%	544
2026 Q1	$1.88K	Hold	21	–	–	﹤0.01%	522
2025 Q4	$1.87K	Hold	21	–	–	﹤0.01%	523
2025 Q3	$2.05K	Hold	21	–	–	﹤0.01%	503
2025 Q2	$1.9K	Hold	21	–	–	﹤0.01%	463
2025 Q1	$2.36K	Hold	21	–	–	﹤0.01%	388
2024 Q4	$2.2K	Hold	21	–	–	﹤0.01%	400
2024 Q3	$2.25K	Hold	21	–	–	﹤0.01%	401
2024 Q2	$2.26K	Hold	21	–	–	﹤0.01%	389
2024 Q1	$2.75K	Hold	21	–	–	﹤0.01%	398
2023 Q4	$2.54K	Hold	21	–	–	﹤0.01%	397
2023 Q3	$2.34K	Hold	21	–	–	﹤0.01%	397
2023 Q2	$3.04K	Hold	21	–	–	﹤0.01%	397
2023 Q1	$2.69K	Hold	21	–	–	﹤0.01%	317
2022 Q4	$2.65K	Hold	21	–	–	﹤0.01%	303
2022 Q3	$2.17K	Hold	21	–	–	﹤0.01%	300
2022 Q2	$2.17K	Hold	21	–	–	﹤0.01%	293
2022 Q1	$2.64K	Sell	21 -1	-5%	-$121	﹤0.01%	298
2021 Q4	$2.62K	Buy	+22	New	+$2.88K	﹤0.01%	297

Other funds holding ZBH

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Wilsey Asset Management San Diego, California $681M AUM 1.1% 1-Year Est. Return

Northside Capital Management Hood River, Oregon $1.25B AUM 16.02% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Gilman Hill Asset Management New Canaan, Connecticut $718M AUM 15.3% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

PFS Partners's ZBH Position: Q3 2026 in Review

PFS Partners sold out of Zimmer Biomet (ZBH) in Q3 2026, closing a stake of 21 shares — an estimated $1.79K sold.

PFS Partners first reported a position in ZBH in Q4 2021 and held it in 19 quarters. The position peaked at $3.04K in Q2 2023. 151 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

PFS Partners reported no remaining Zimmer Biomet position as of Q3 2026 after selling out during the quarter.
PFS Partners sold 21 Zimmer Biomet shares in Q3 2026, an estimated $1.79K.
PFS Partners first reported a position in Zimmer Biomet in Q4 2021 and held it in 19 quarters.
PFS Partners's Zimmer Biomet position peaked at $3.04K in Q2 2023.
151 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on PFS Partners's 13F filing for Q3 2026, filed 21 Oct 2026.